285 related articles for article (PubMed ID: 29554887)
1. CircRNAs as biomarkers of cancer: a meta-analysis.
Wang M; Yang Y; Xu J; Bai W; Ren X; Wu H
BMC Cancer; 2018 Mar; 18(1):303. PubMed ID: 29554887
[TBL] [Abstract][Full Text] [Related]
2. Abnormally Expressed Circular RNAs are Promising Biomarkers for Diagnosis of Hepatocellular Carcinoma: a Meta-Analysis.
Yu G; Yang L; Zhou J; Zhang L; Xia L
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710441
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA Hsa_Circ_0091579 Serves as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
Zhang C; Zhang C; Lin J; Wang H
Cell Physiol Biochem; 2018; 51(1):290-300. PubMed ID: 30453307
[TBL] [Abstract][Full Text] [Related]
4. The Role of circRNAs in the Diagnosis of Colorectal Cancer: A Meta-Analysis.
Li RD; Guan M; Zhou Z; Dong SX; Liu Q
Front Med (Lausanne); 2021; 8():766208. PubMed ID: 34869475
[No Abstract] [Full Text] [Related]
5. Systematic Review and Meta-Analysis of the Utility of Circular RNAs as Biomarkers of Hepatocellular Carcinoma.
Hao Q; Han Y; Xia W; Wang Q; Qian H
Can J Gastroenterol Hepatol; 2019; 2019():1684039. PubMed ID: 31187026
[TBL] [Abstract][Full Text] [Related]
6. Value of miR-21 levels as potential biomarkers in the early diagnosis of hepatocellular carcinomaļ¼a meta-analysis.
Zhang H; Ding R; Chen D
Biomarkers; 2021 Nov; 26(7):586-597. PubMed ID: 34266326
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and diagnostic significance of circRNAs expression in hepatocellular carcinoma patients: A meta-analysis.
Huang X; Zhang W; Shao Z
Cancer Med; 2019 Mar; 8(3):1148-1156. PubMed ID: 30693679
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNAs as biomarkers for the diagnosis of hepatocellular carcinoma: A meta-analysis.
Zeng C; Tang Y; Jiang Y; Zuo Z; Tao H
Pathol Res Pract; 2021 Aug; 224():153546. PubMed ID: 34332221
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of long noncoding RNAs for hepatocellular carcinoma: A PRISMA-compliant meta-analysis.
Hao QQ; Chen GY; Zhang JH; Sheng JH; Gao Y
Medicine (Baltimore); 2017 Jul; 96(28):e7496. PubMed ID: 28700498
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of lncRNAs as Biomarker in Hepatocellular Carcinoma: An Updated Meta-Analysis.
Chen S; Zhang Y; Wu X; Zhang C; Li G
Can J Gastroenterol Hepatol; 2018; 2018():8410195. PubMed ID: 30410873
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of CircRNAs as Potential Biomarkers in Oral Squamous Cell Carcinoma: a Meta-Analysis.
Wang M; Zhang L; Ren W; Li S; Zhi K; Zheng J; Gao L
Front Oncol; 2021; 11():693284. PubMed ID: 34307158
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNAs as novel serum biomarkers for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.
Zheng C; Hao H; Chen L; Shao J
Clin Transl Oncol; 2017 Aug; 19(8):961-968. PubMed ID: 28188488
[TBL] [Abstract][Full Text] [Related]
13. Comparison osteopontin vs AFP for the diagnosis of HCC: a meta-analysis.
Wan HG; Xu H; Gu YM; Wang H; Xu W; Zu MH
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):706-14. PubMed ID: 25034355
[TBL] [Abstract][Full Text] [Related]
14. Can serum glypican-3 be a biomarker for effective diagnosis of hepatocellular carcinoma? A meta-analysis of the literature.
Yang SL; Fang X; Huang ZZ; Liu XJ; Xiong ZF; Liu P; Yao HY; Li CH
Dis Markers; 2014; 2014():127831. PubMed ID: 25378766
[TBL] [Abstract][Full Text] [Related]
15. Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma.
Qin M; Liu G; Huo X; Tao X; Sun X; Ge Z; Yang J; Fan J; Liu L; Qin W
Cancer Biomark; 2016; 16(1):161-9. PubMed ID: 26600397
[TBL] [Abstract][Full Text] [Related]
16. CircRNAs as promising biomarker in diagnosis of breast cancer: An updated meta-analysis.
Chu M; Fang Y; Jin Y
J Clin Lab Anal; 2021 Sep; 35(9):e23934. PubMed ID: 34331339
[TBL] [Abstract][Full Text] [Related]
17. Circular RNAs as diagnostic biomarkers in gastric cancer: A meta-analysis review.
Jiang F; Hong F; Shah MW; Shen X
Pathol Res Pract; 2019 Jun; 215(6):152419. PubMed ID: 31043351
[TBL] [Abstract][Full Text] [Related]
18. Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis.
Liao W; Mao Y; Ge P; Yang H; Xu H; Lu X; Sang X; Zhong S
Medicine (Baltimore); 2015 Apr; 94(14):e722. PubMed ID: 25860220
[TBL] [Abstract][Full Text] [Related]
19. Circulating miR-21 as a potential biomarker in human digestive system carcinoma: a systematic review and diagnostic meta-analysis.
Aalami AH; Abdeahad H; Mesgari M
Biomarkers; 2021 Mar; 26(2):103-113. PubMed ID: 33434077
[No Abstract] [Full Text] [Related]
20. Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis.
Yu J; Wang ZJ; Chen LH; Dong WZ
Scand J Clin Lab Invest; 2017 Feb; 77(1):8-14. PubMed ID: 27762143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
